SKI Market

A+| A| A-|

Indian Indices

Sensex

77,100.47 109.25
( 0.14%)

Global Indices

Nasdaq

51,927.61 57.71
(0.11%)

Dow Jones

7,374.18 -5.04
(-0.07%)

Hang Seng

72,467.78 3,292.81
(4.76%)

Nikkei 225

10,536.79 75.16
(0.72%)

Forex

USD-INR

94.55 -0.19
(-0.20%)

EUR-INR

107.36 -0.64
(-0.59%)

GBP-INR

124.56 -0.65
(-0.52%)

JPY-INR

0.58 0.00
(-0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524824

INE083D01012

65.3864135

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALPHARMA

19.72

133.1

EPS(TTM)

Face Value()

Div & Yield %

4.24

1.44

Back

Deccan Gold Mines reports consolidated net loss of Rs 18.92 crore in the December 2025 quarter

Feb 14,2026

Net Loss of Deccan Gold Mines reported to Rs 18.92 crore in the quarter ended December 2025 as against net loss of Rs 21.04 crore during the previous quarter ended December 2024. Sales declined 93.85% to Rs 0.04 crore in the quarter ended December 2025 as against Rs 0.65 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.04	0.65	-94
OPM %	-25250.00	-3461.54	-
PBDT	-16.33	-22.50	27
PBT	-19.58	-25.70	24
NP	-18.92	-21.04	10

77,100.47 109.25 ( 0.14%)

51,927.61 57.71 (0.11%)

7,374.18 -5.04 (-0.07%)

72,467.78 3,292.81 (4.76%)

10,536.79 75.16 (0.72%)

94.55 -0.19 (-0.20%)

107.36 -0.64 (-0.59%)

124.56 -0.65 (-0.52%)

0.58 0.00 (-0.30%)